[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Psychedelic Medicine Market Research Report 2021-2025

April 2021 | 165 pages | ID: G7B80942444CEN
9Dimen Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Psychedelic medicines also called as hallucinogenics, are a group of substances including chemicals, such as LSD, and plants that are used in the treatment of various mental disorders such as resistant depression, panic disorder, opiate addiction, etc. In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Psychedelic Medicine Report by Material, Application, and Geography – Global Forecast to 2025 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Psychedelic Medicine market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025.

The report firstly introduced the Psychedelic Medicine basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The major players profiled in this report include:
Roche Holding AG
Pfizer Inc.
The Emmes Company LLC
COMPASS Group plc
Merck & Co. Inc.
AstraZeneca PLC
AbbVie Inc.
Mylan N.V.
Alkermes plc
Dr. Reddy’s Laboratories
The Takeda Pharmaceutical Company Limited
H. Lundbeck A/S
Jonhson & Johnson
Numinus Wellness
Mota Ventures Corp.
Mind medicine (MindMed) Inc.
Eli Lilly and Company
Teva Pharmceuticals Industries Ltd.
Novartis International AG
GlaxoSmithKline plc Sanofi

The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
Oral
Injectable
Inhalation

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Psychedelic Medicine for each application, including-
Hospital Pharmacies
Retailer Pharmacies
Online Pharmacies
PART I PSYCHEDELIC MEDICINE INDUSTRY OVERVIEW

CHAPTER ONE PSYCHEDELIC MEDICINE INDUSTRY OVERVIEW

1.1 Psychedelic Medicine Definition
1.2 Psychedelic Medicine Classification Analysis
  1.2.1 Psychedelic Medicine Main Classification Analysis
  1.2.2 Psychedelic Medicine Main Classification Share Analysis
1.3 Psychedelic Medicine Application Analysis
  1.3.1 Psychedelic Medicine Main Application Analysis
  1.3.2 Psychedelic Medicine Main Application Share Analysis
1.4 Psychedelic Medicine Industry Chain Structure Analysis
1.5 Psychedelic Medicine Industry Development Overview
  1.5.1 Psychedelic Medicine Product History Development Overview
  1.5.1 Psychedelic Medicine Product Market Development Overview
1.6 Psychedelic Medicine Global Market Comparison Analysis
  1.6.1 Psychedelic Medicine Global Import Market Analysis
  1.6.2 Psychedelic Medicine Global Export Market Analysis
  1.6.3 Psychedelic Medicine Global Main Region Market Analysis
  1.6.4 Psychedelic Medicine Global Market Comparison Analysis
  1.6.5 Psychedelic Medicine Global Market Development Trend Analysis

CHAPTER TWO PSYCHEDELIC MEDICINE UP AND DOWN STREAM INDUSTRY ANALYSIS

2.1 Upstream Raw Materials Analysis
  2.1.1 Proportion of Manufacturing Cost
  2.1.2 Manufacturing Cost Structure of Psychedelic Medicine Analysis
2.2 Down Stream Market Analysis
  2.2.1 Down Stream Market Analysis
  2.2.2 Down Stream Demand Analysis
  2.2.3 Down Stream Market Trend Analysis

PART II ASIA PSYCHEDELIC MEDICINE INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)

CHAPTER THREE ASIA PSYCHEDELIC MEDICINE MARKET ANALYSIS

3.1 Asia Psychedelic Medicine Product Development History
3.2 Asia Psychedelic Medicine Competitive Landscape Analysis
3.3 Asia Psychedelic Medicine Market Development Trend

CHAPTER FOUR 2016-2021 ASIA PSYCHEDELIC MEDICINE PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST

4.1 2016-2021 Psychedelic Medicine Production Overview
4.2 2016-2021 Psychedelic Medicine Production Market Share Analysis
4.3 2016-2021 Psychedelic Medicine Demand Overview
4.4 2016-2021 Psychedelic Medicine Supply Demand and Shortage
4.5 2016-2021 Psychedelic Medicine Import Export Consumption
4.6 2016-2021 Psychedelic Medicine Cost Price Production Value Gross Margin

CHAPTER FIVE ASIA PSYCHEDELIC MEDICINE KEY MANUFACTURERS ANALYSIS

5.1 Company A
  5.1.1 Company Profile
  5.1.2 Product Picture and Specification
  5.1.3 Product Application Analysis
  5.1.4 Capacity Production Price Cost Production Value
  5.1.5 Contact Information
5.2 Company B
  5.2.1 Company Profile
  5.2.2 Product Picture and Specification
  5.2.3 Product Application Analysis
  5.2.4 Capacity Production Price Cost Production Value
  5.2.5 Contact Information
5.3 Company C
  5.3.1 Company Profile
  5.3.2 Product Picture and Specification
  5.3.3 Product Application Analysis
  5.3.4 Capacity Production Price Cost Production Value
  5.3.5 Contact Information
5.4 Company D
  5.4.1 Company Profile
  5.4.2 Product Picture and Specification
  5.4.3 Product Application Analysis
  5.4.4 Capacity Production Price Cost Production Value
  5.4.5 Contact Information

CHAPTER SIX ASIA PSYCHEDELIC MEDICINE INDUSTRY DEVELOPMENT TREND

6.1 2021-2025 Psychedelic Medicine Production Overview
6.2 2021-2025 Psychedelic Medicine Production Market Share Analysis
6.3 2021-2025 Psychedelic Medicine Demand Overview
6.4 2021-2025 Psychedelic Medicine Supply Demand and Shortage
6.5 2021-2025 Psychedelic Medicine Import Export Consumption
6.6 2021-2025 Psychedelic Medicine Cost Price Production Value Gross Margin

PART III NORTH AMERICAN PSYCHEDELIC MEDICINE INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)

CHAPTER SEVEN NORTH AMERICAN PSYCHEDELIC MEDICINE MARKET ANALYSIS

7.1 North American Psychedelic Medicine Product Development History
7.2 North American Psychedelic Medicine Competitive Landscape Analysis
7.3 North American Psychedelic Medicine Market Development Trend

CHAPTER EIGHT 2016-2021 NORTH AMERICAN PSYCHEDELIC MEDICINE PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST

8.1 2016-2021 Psychedelic Medicine Production Overview
8.2 2016-2021 Psychedelic Medicine Production Market Share Analysis
8.3 2016-2021 Psychedelic Medicine Demand Overview
8.4 2016-2021 Psychedelic Medicine Supply Demand and Shortage
8.5 2016-2021 Psychedelic Medicine Import Export Consumption
8.6 2016-2021 Psychedelic Medicine Cost Price Production Value Gross Margin

CHAPTER NINE NORTH AMERICAN PSYCHEDELIC MEDICINE KEY MANUFACTURERS ANALYSIS

9.1 Company A
  9.1.1 Company Profile
  9.1.2 Product Picture and Specification
  9.1.3 Product Application Analysis
  9.1.4 Capacity Production Price Cost Production Value
  9.1.5 Contact Information
9.2 Company B
  9.2.1 Company Profile
  9.2.2 Product Picture and Specification
  9.2.3 Product Application Analysis
  9.2.4 Capacity Production Price Cost Production Value
  9.2.5 Contact Information

CHAPTER TEN NORTH AMERICAN PSYCHEDELIC MEDICINE INDUSTRY DEVELOPMENT TREND

10.1 2021-2025 Psychedelic Medicine Production Overview
10.2 2021-2025 Psychedelic Medicine Production Market Share Analysis
10.3 2021-2025 Psychedelic Medicine Demand Overview
10.4 2021-2025 Psychedelic Medicine Supply Demand and Shortage
10.5 2021-2025 Psychedelic Medicine Import Export Consumption
10.6 2021-2025 Psychedelic Medicine Cost Price Production Value Gross Margin

PART IV EUROPE PSYCHEDELIC MEDICINE INDUSTRY ANALYSIS (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)

CHAPTER ELEVEN EUROPE PSYCHEDELIC MEDICINE MARKET ANALYSIS

11.1 Europe Psychedelic Medicine Product Development History
11.2 Europe Psychedelic Medicine Competitive Landscape Analysis
11.3 Europe Psychedelic Medicine Market Development Trend

CHAPTER TWELVE 2016-2021 EUROPE PSYCHEDELIC MEDICINE PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST

12.1 2016-2021 Psychedelic Medicine Production Overview
12.2 2016-2021 Psychedelic Medicine Production Market Share Analysis
12.3 2016-2021 Psychedelic Medicine Demand Overview
12.4 2016-2021 Psychedelic Medicine Supply Demand and Shortage
12.5 2016-2021 Psychedelic Medicine Import Export Consumption
12.6 2016-2021 Psychedelic Medicine Cost Price Production Value Gross Margin

CHAPTER THIRTEEN EUROPE PSYCHEDELIC MEDICINE KEY MANUFACTURERS ANALYSIS

13.1 Company A
  13.1.1 Company Profile
  13.1.2 Product Picture and Specification
  13.1.3 Product Application Analysis
  13.1.4 Capacity Production Price Cost Production Value
  13.1.5 Contact Information
13.2 Company B
  13.2.1 Company Profile
  13.2.2 Product Picture and Specification
  13.2.3 Product Application Analysis
  13.2.4 Capacity Production Price Cost Production Value
  13.2.5 Contact Information

CHAPTER FOURTEEN EUROPE PSYCHEDELIC MEDICINE INDUSTRY DEVELOPMENT TREND

14.1 2021-2025 Psychedelic Medicine Production Overview
14.2 2021-2025 Psychedelic Medicine Production Market Share Analysis
14.3 2021-2025 Psychedelic Medicine Demand Overview
14.4 2021-2025 Psychedelic Medicine Supply Demand and Shortage
14.5 2021-2025 Psychedelic Medicine Import Export Consumption
14.6 2021-2025 Psychedelic Medicine Cost Price Production Value Gross Margin

PART V PSYCHEDELIC MEDICINE MARKETING CHANNELS AND INVESTMENT FEASIBILITY

CHAPTER FIFTEEN PSYCHEDELIC MEDICINE MARKETING CHANNELS DEVELOPMENT PROPOSALS ANALYSIS

15.1 Psychedelic Medicine Marketing Channels Status
15.2 Psychedelic Medicine Marketing Channels Characteristic
15.3 Psychedelic Medicine Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals

CHAPTER SIXTEEN DEVELOPMENT ENVIRONMENTAL ANALYSIS

16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis

CHAPTER SEVENTEEN PSYCHEDELIC MEDICINE NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS

17.1 Psychedelic Medicine Market Analysis
17.2 Psychedelic Medicine Project SWOT Analysis
17.3 Psychedelic Medicine New Project Investment Feasibility Analysis

PART VI GLOBAL PSYCHEDELIC MEDICINE INDUSTRY CONCLUSIONS

CHAPTER EIGHTEEN 2016-2021 GLOBAL PSYCHEDELIC MEDICINE PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST

18.1 2016-2021 Psychedelic Medicine Production Overview
18.2 2016-2021 Psychedelic Medicine Production Market Share Analysis
18.3 2016-2021 Psychedelic Medicine Demand Overview
18.4 2016-2021 Psychedelic Medicine Supply Demand and Shortage
18.5 2016-2021 Psychedelic Medicine Import Export Consumption
18.6 2016-2021 Psychedelic Medicine Cost Price Production Value Gross Margin

CHAPTER NINETEEN GLOBAL PSYCHEDELIC MEDICINE INDUSTRY DEVELOPMENT TREND

19.1 2021-2025 Psychedelic Medicine Production Overview
19.2 2021-2025 Psychedelic Medicine Production Market Share Analysis
19.3 2021-2025 Psychedelic Medicine Demand Overview
19.4 2021-2025 Psychedelic Medicine Supply Demand and Shortage
19.5 2021-2025 Psychedelic Medicine Import Export Consumption
19.6 2021-2025 Psychedelic Medicine Cost Price Production Value Gross Margin

CHAPTER TWENTY GLOBAL PSYCHEDELIC MEDICINE INDUSTRY RESEARCH CONCLUSIONS


More Publications